Balentine LLC Takeda Pharmaceutical CO LTD Transaction History

Balentine LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$17.1 - $19.19 $37,312 - $41,872	-2,182 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $31,835 - $42,549	2,182 New	2,182 $39,000
Q4 2019 Sep 02, 2020	SELL	$16.88 - $20.83 $15,023 - $18,538	-890 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$16.15 - $17.99 $2,842 - $3,166	-176 Reduced 16.51%	890 $15,000
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $3,564 - $4,405	215 Added 25.26%	1,066 $19,000
Q1 2019 May 16, 2019	BUY	$16.7 - $21.52 $14,211 - $18,313	851 New	851 $17,000

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.